The Century Co., Ltd. (KRX:002420)
5,680.00
+140.00 (2.53%)
At close: Oct 2, 2025
The Century Revenue
In the year 2016, The Century had annual revenue of 5.47B KRW, down -0.20%. The Century had revenue of 1.39B in the quarter ending December 31, 2016, a decrease of -2.18%.
Revenue
5.47B
Revenue Growth
-0.20%
P/S Ratio
6.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
33.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2016 | 5.47B | -10.92M | -0.20% |
Dec 31, 2015 | 5.48B | -58.16M | -1.05% |
Dec 31, 2014 | 5.54B | 343.61M | 6.62% |
Dec 31, 2013 | 5.19B | -912.29M | -14.95% |
Dec 31, 2012 | 6.10B | 74.89M | 1.24% |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NAVER | 11.30T |
Kakao | 7,770.49B |
KRAFTON | 2,873.07B |
KT Corporation | 27.50T |
SK Telecom | 17.87T |
HYBE Co., Ltd. | 2,460.53B |
LG Uplus | 15.15T |
Netmarble | 2,637.83B |
The Century News
- 4 days ago - Insider Decision: Agust F Hafberg Offloads $264K Worth Of Century Aluminum Stock - Benzinga
- 5 days ago - Century (CENX) Is a Great Choice for 'Trend' Investors, Here's Why - Nasdaq
- 11 days ago - Sell Alert: Kenneth L Calloway Cashes Out $452K In Century Aluminum Stock - Benzinga
- 20 days ago - Earnings Estimates Rising for Century (CENX): Will It Gain? - Nasdaq
- 21 days ago - Century (CENX) Moves 6.4% Higher: Will This Strength Last? - Nasdaq
- 7 weeks ago - Century Aluminum SVP Trades $279K In Company Stock - Benzinga
- 7 weeks ago - Century Reports Flat Loss in Fiscal Q2 - The Motley Fool
- 5 months ago - Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - Benzinga